Safety and Efficacy of Obicetrapib for Atherogenic Lipid Reduction: A Systematic Review and Meta-Analysis
Saqib Ali, Adel Mansour, Maheen Sheraz, Zohaib Ali et autres
Cardiovascular risk remains elevated in hyperlipidemic patients despite standard lipid-lowering therapy, with dyslipidemia persisting as a key contributor. We conducted a meta-analysis to investigate the effectiveness and safety of obicetrapib, a selective cholesteryl ester transfer protein inhibitor, in improving lipid parameters and …
pk, Égypte, us (code pays fourni par la source)